AHA Regarding the 340B Program

AHA to the Subcommittee on Oversight and Investigations Committee on Energy and Commerce regarding the 340B program.

Related Resources

Letter/Comment
The AHA and five other health care organizations sent the attached letter to HHS Secretary Becerra urging him to stop the actions of six drug companies that…
Letter/Comment
Public
AHA urges the Department of Health and Human Services (HHS) to ensure hospitals currently participating in the 340B Drug Pricing Program continue to have…
Letter/Comment
Public
The AHA asks that commissioners consider the following issues as they recommend changes that would have a significant impact on hospitals, health systems and…
Letter/Comment
Public
AHA letter to Senators, John Thune, Rob Portman, Shelley Moore Capito, Tammy Baldwin, Debbie Stabenow and Ben Cardin expressing support for legislation, S. 773.
Fact Sheets
Public
For more than 25 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription…
Fact Sheets
Public
For nearly 30 years, the 340B Drug Pricing Program has provided financial help to safety-net hospitals to manage rising prescription drug costs. Section 340B…